Clinical Trial Update: Immuno-monitoring of Patients With Metastatic Melanoma (AJCC Stadium IV) Under Chemotherapy

View source ↗

Summary

This document notes the completion of a clinical trial evaluating immuno-monitoring in patients with metastatic melanoma (AJCC Stage IV) undergoing chemotherapy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Snippet

Sponsor: Universitätsmedizin Mannheim | Conditions: Immuno-monitoring | Status: COMPLETED